Gut overgrowth harms the critically ill patient requiring treatment on the intensive care unit

Signa Vitae

Volumn 7, Issue 1, 2012, Pages 7-9

  van Saen, Hendrik ^a   Silvestri, Luciano ^b   Taylor, Nia ^a   Zandstra, Durk ^c   De La Cal, Miguel ^d   Petros, Andy ^e  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Unit of Anesthesia and Intensive Care   (Italy)

^c ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^d HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^e GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

'Abnormal' potential pathogens; 'Normal' potential pathogens; Diagnostic samples; Overgrowth; Selective digestive decontamination (SDD); Surveillance samples

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; CEFOTAXIME; COLISTIN; NYSTATIN; POLYENE; POLYMYXIN; TOBRAMYCIN; VANCOMYCIN;

ASEPSIS; BACTEREMIA; BACTERIAL OVERGROWTH; BACTERIAL TRANSLOCATION; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BIOSURVEILLANCE; CANDIDA ALBICANS; CONCENTRATION RESPONSE; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DRUG CONTRAINDICATION; ERADICATION THERAPY; HUMAN; INFECTION CONTROL; INFECTION RATE; INTENSIVE CARE UNIT; INTESTINE FLORA; LOWER RESPIRATORY TRACT INFECTION; NONHUMAN; REVIEW; TREATMENT DURATION; TREATMENT PLANNING;

EID: 84861012329     PISSN: 13345605     EISSN: 1845206X     Source Type: Journal    
DOI: 10.22514/sv71.042012.1     Document Type: Review

References (20)

1. Centers for Disease Control (CDC) Guidelines. Guidelines for surveillance and control of nosocomial infections. US Department of Helth and Human Services. Public Health Service. Centers for Disease Control, Atlanta, Georgia. 1985: pp 40-4.
2. Stoutenbeek CP. Infection prevention in intensive care. PhD Thesis, van Denderen BV, Groningen, 1987.
3. Schimpff SC, Miller RM, Polakavetz S, Hornick RB. Infection in the severely traumatized patient. Ann Surg 1974;179:352-7.
4. Schimpff SC. Surveillance cultures. J Infect Dis 1981;144:81-4.
5. Johanson WG, Pierce AK, Sanford JP. Changing pharyngeal bacterial flora of hospitalised patients. Emergence of Gram-negative bacilli. New Engl J Med 1969;231:1137-40.
6. Everett ED, McNitt ThR, Rahm AE, Stevens DL, Peterson HE. Epidemiological investigation of methicillin-resistant Staphylococcus aureus in a burn unit. Mil Med 1978;143:165-7.
7. Deitch EA, Maejima K, Berg R. Effect of oral antibiotics and bacterial overgrowth on the translocation of the GI tract microflora in burned rats. J Trauma 1985;25:385-92.
8. Stoutenbeek CP, van Saene HKF, Miranda DR, Zandstra DF. The effect of selective decontamination of the digestive tract on colonization and infection rates in multiple trauma patients. Intens Care Med 1984;10:185-92.
9. Van Uffelen R, van Saene HKF, Fidler, Lowenberg A. Oropharyngeal flora as a source of bacteria colonizing the lower airways in patients on artificial ventilation. Intens Care Med 1984;10:233-7.
10. Neu HC, Aswapokee N, Aswapokee P, Fu KP. HR 756, a new cephalosporin active against Gram-positive and Gram-negative aerobic and anaerobic bacteria. Antimicrob Ag Chemother 1979;15:279-81.
11. Novick WJ Jr. Levels of cefotaxime in body fluids and tissues: a review. Rev Infect Dis 1982; 4Suppl: S346-53.
12. Hofstra W, de Vries-Hospers HG, van der Waaij D. Concentrations of nystatin in faeces after oral administration of various doses of nystatin. Infection 1979;7:166-70.
13. Hofstra W, de Vries-Hospers HG, van der Waaij D. Concentrations of amphotericin B in faeces and blood of healthy volunteers after the oral administration of various doses. Infection 1982;10:223-7.
14. Gotoff SP, Lepper MH, Fiedler MA. Treatment of salmonella carriers with colistin sulfate. Am J Med Sci 1965;249:399-403.
15. Mulder JG, Wiersma WE, Welling GW, van der Waay D. Low dose oral tobramycin treatment for selective decontamination of the digestive tract: a study in human volunteers. J Antimicrob Chemother 1984;13:495-504.
16. Geraci JE, Heilman FR, Nichols DR, Wellman WE, Ross CT. Some laboratory and clinical experience with a new antibiotic, vancomycin. Proc Staff Meet Mayo Clin 1956;31:564-82.
17. Petros AJ, Taylor N, van Saene HKF, Silvestri L. Gut overgrowth harms the critically ill. Intens Care Med 2011; in press
18. Silvestri L, Petros AJ, Zandstra DF, Taylor N, van Saene HKF. SDD reduces bacteremia following eradication of gut overgrowth. Crit Care Med 2011; accepted.
19. Zandstra DF, Petros AJ, Silvestri L, de la Cal MA, Taylor N, Damjanovic V, van Saene HKF. Selective decontamination of the digestive tract: selectivity is not required. Intens Care Med 2010;36:1783-4.
20. Poth EJ. Historical development of intestinal antisepsis. World J Surg 1982;6:153-9.